Leadman Biochemistry shareholders approve new director, charter revisions

Beijing Leadman Biochemistry Co., Ltd. held its first extraordinary general meeting of shareholders for 2025 on November 21, 2025. A total of 386 shareholders and proxies, representing 258,020,202 shares with voting rights, or 47.4292% of total shares, participated. The meeting combined on-site and online voting methods.

Shareholders approved the proposal to elect Mr. Liao Zihua as a non-independent director to the Sixth Board of Directors with 99.4898% of votes in favor (256,703,852 shares). Separately, the resolution to revise the "Company Articles of Association" and its annexes passed with 99.5017% of votes in favor (256,734,452 shares). This resolution, being a special resolution, received approval from more than two-thirds of the voting rights held by shareholders present.

The meeting confirmed that no proposals were rejected and no previous shareholder resolutions were altered. Attorneys from Beijing Dacheng Law Firm verified the legality of the meeting's convening, procedures, and resolutions.